Could a common antibiotic ease two gut and liver diseases at once?

NCT ID NCT07341282

First seen Jan 16, 2026 · Last updated May 24, 2026 · Updated 21 times

Summary

This study tests whether the antibiotic vancomycin can safely improve symptoms of ulcerative colitis in adults who also have a liver condition called primary sclerosing cholangitis. Fourteen participants will take vancomycin or a placebo for 4 weeks, with an option for 4 more weeks of vancomycin. The main goal is to see if the study is feasible and safe, and to look for early signs of benefit.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY SCLEROSING CHOLANGITIS (PSC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • McMaster Children's Hospital - Digestive Diseases Clinic

    Hamilton, Ontario, L8N 3Z5, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.